Clinical Trial Update: A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial comparing once-weekly lonapegsomatropin with placebo and daily somatropin in adults with growth hormone deficiency has completed, with trial resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Skytrofa (lonapegsomatropin)
• lonapegsomatropin (lonapegsomatropin)

Snippet

Sponsor: Ascendis Pharma Endocrinology Division A/S | Conditions: Growth Hormone Deficiency, Endocrine System Diseases | Phase 3 | Status: COMPLETED | Results posted: 2025-01-15